ExploreWatchlistsPricing
  1. US-listed companies
  2. Axsome Therapeutics, Inc.
  3. Financials
  4. Accounts payable

Axsome Therapeutics, Inc. (AXSM)

Market cap
$12.1B
P/E ratio
SummaryFinancials
Period EndAccounts payable (Million USD)YoY (%)
Dec 31, 202566-8.97%
Dec 31, 202472+76.99%
Dec 31, 202341+5.37%
Dec 31, 202239+193.59%
Dec 31, 202113-2.63%
Dec 31, 202014+23.40%
Dec 31, 201911+196.79%
Dec 31, 20184+7.33%
Dec 31, 20173-15.82%
Dec 31, 20164

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat